APA (7th ed.) Citation

C, L., JW, L., CH, W., YJ, H., SW, L., TY, H., . . . FC, L. (2026). Adjuvant Molecular Hydrogen Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report on Immunomodulatory Effects on Regulatory and Effector Lymphocytes. In vivo (Athens, Greece), 40(1), 551. https://doi.org/10.21873/invivo.14220

Chicago Style (17th ed.) Citation

C, Liu, Lu JW, Wu CH, Ho YJ, Lui SW, Hsieh TY, Wang KY, and Liu FC. "Adjuvant Molecular Hydrogen Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report on Immunomodulatory Effects on Regulatory and Effector Lymphocytes." In Vivo (Athens, Greece) 40, no. 1 (2026): 551. https://doi.org/10.21873/invivo.14220.

MLA (9th ed.) Citation

C, Liu, et al. "Adjuvant Molecular Hydrogen Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report on Immunomodulatory Effects on Regulatory and Effector Lymphocytes." In Vivo (Athens, Greece), vol. 40, no. 1, 2026, p. 551, https://doi.org/10.21873/invivo.14220.